Cargando…

SARS-CoV-2 neutralizing antibody responses are more robust in patients with severe disease

We studied plasma antibody responses of 35 patients about 1 month after SARS-CoV-2 infection. Titers of antibodies binding to the viral nucleocapsid and spike proteins were significantly higher in patients with severe disease. Likewise, mean antibody neutralization titers against SARS-CoV-2 pseudovi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Pengfei, Liu, Lihong, Nair, Manoj S., Yin, Michael T., Luo, Yang, Wang, Qian, Yuan, Ting, Mori, Kanako, Solis, Axel Guzman, Yamashita, Masahiro, Garg, Ankur, Purpura, Lawrence J., Laracy, Justin C., Yu, Jian, Joshua-Tor, Leemor, Sodroski, Joseph, Huang, Yaoxing, Ho, David D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7534308/ https://www.ncbi.nlm.nih.gov/pubmed/32930052 http://dx.doi.org/10.1080/22221751.2020.1823890

Ejemplares similares

Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization
por: Wang, Pengfei, et al.
Publicado: (2021)

Increased Resistance of SARS-CoV-2 Variant P.1 to Antibody Neutralization
por: Wang, Pengfei, et al.
Publicado: (2021)

Functional differences among the spike glycoproteins of multiple emerging severe acute respiratory syndrome coronavirus 2 variants of concern
por: Wang, Qian, et al.
Publicado: (2021)

Changes in serum-neutralizing antibody potency and breadth post-SARS-CoV-2 mRNA vaccine boost
por: Nair, Manoj S., et al.
Publicado: (2023)

Neutralizing antibody 5-7 defines a distinct site of vulnerability in SARS-CoV-2 spike N-terminal domain
por: Cerutti, Gabriele, et al.
Publicado: (2021)

A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses
por: Wang, Pengfei, et al.
Publicado: (2021)

A monoclonal antibody that neutralizes SARS-CoV-2 variants, SARS-CoV, and other sarbecoviruses
por: Wang, Pengfei, et al.
Publicado: (2021)

Developmental roles and molecular mechanisms of Asterix/GTSF1
por: Ipsaro, Jonathan J., et al.
Publicado: (2022)

Increased Resistance of SARS-CoV-2 Variants B.1.351 and B.1.1.7 to Antibody Neutralization
por: Wang, Pengfei, et al.
Publicado: (2021)

Mechanism of Dis3L2 substrate recognition in the Lin28/let-7 pathway
por: Faehnle, Christopher R., et al.
Publicado: (2014)

Multi-domain utilization by TUT4 and TUT7 in control of let-7 biogenesis
por: Faehnle, Christopher R., et al.
Publicado: (2017)

Near-Neutrality, Robustness, and Epigenetics
por: Ohta, Tomoko
Publicado: (2011)

Potent SARS-CoV-2 neutralizing antibodies directed against spike N-terminal domain target a single supersite
por: Cerutti, Gabriele, et al.
Publicado: (2021)

Robustness of signal detection in cryo-electron microscopy via a bi-objective-function approach
por: Wang, Wei Li, et al.
Publicado: (2019)

Ad26.COV2.S boosts antibody and T-cell responses following BNT162b2 vaccination
por: Iketani, Sho, et al.
Publicado: (2021)

Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies
por: Cerutti, Gabriele, et al.
Publicado: (2021)

Recombination and mutational robustness in neutral fitness landscapes
por: Klug, Alexander, et al.
Publicado: (2019)

The Chp1-Tas3 core is a multifunctional platform critical for gene silencing by RITS
por: Schalch, Thomas, et al.
Publicado: (2011)

Target binding triggers hierarchical phosphorylation of human Argonaute-2 to promote target release
por: Bibel, Brianna, et al.
Publicado: (2022)

A shape-shifting nuclease unravels structured RNA
por: Meze, Katarina, et al.
Publicado: (2023)

The dynamic nature of the human origin recognition complex revealed through five cryoEM structures
por: Jaremko, Matt J, et al.
Publicado: (2020)

Neutrality and Robustness in Evo-Devo: Emergence of Lateral Inhibition
por: Munteanu, Andreea, et al.
Publicado: (2008)

A Robust Neutralization Test for Plasmodium falciparum Malaria
por: Saul, Allan, et al.
Publicado: (2001)

Modular basis for potent SARS-CoV-2 neutralization by a prevalent VH1-2-derived antibody class
por: Rapp, Micah, et al.
Publicado: (2021)

The structural biochemistry of Zucchini implicates it as a nuclease in piRNA biogenesis
por: Ipsaro, Jonathan J., et al.
Publicado: (2012)

High-resolution cryo-EM structures of outbreak strain human norovirus shells reveal size variations
por: Jung, James, et al.
Publicado: (2019)

Conflicting effects of recombination on the evolvability and robustness in neutrally evolving populations
por: Klug, Alexander, et al.
Publicado: (2022)

Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants
por: Xu, Jianliang, et al.
Publicado: (2021)

An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses
por: Liu, Lihong, et al.
Publicado: (2022)

Further results on robust stability for uncertain neutral systems with distributed delay
por: Wu, Tao, et al.
Publicado: (2018)

Structure of the active form of human origin recognition complex and its ATPase motor module
por: Tocilj, Ante, et al.
Publicado: (2017)

siRNA carrying an (E)-vinylphosphonate moiety at the 5΄ end of the guide strand augments gene silencing by enhanced binding to human Argonaute-2
por: Elkayam, Elad, et al.
Publicado: (2017)

siRNA carrying an (E)-vinylphosphonate moiety at the 5΄ end of the guide strand augments gene silencing by enhanced binding to human Argonaute-2
por: Elkayam, Elad, et al.
Publicado: (2017)

Prolonged severe acute respiratory syndrome coronavirus 2 persistence, attenuated immunologic response, and viral evolution in a solid organ transplant patient
por: Purpura, Lawrence J., et al.
Publicado: (2022)

Robust neutralizing antibodies to SARS-CoV-2 infection persist for months
por: Wajnberg, Ania, et al.
Publicado: (2020)

An airway organoid-based screen identifies a role for the HIF1α-glycolysis axis in SARS-CoV-2 infection
por: Duan, Xiaohua, et al.
Publicado: (2021)

Paired heavy- and light-chain signatures contribute to potent SARS-CoV-2 neutralization in public antibody responses
por: Banach, Bailey B., et al.
Publicado: (2021)

Robust in vitro assay for analyzing the neutralization activity of serum specimens against hepatitis B virus
por: Zhang, Ya-Li, et al.
Publicado: (2019)

Vaccination before or after SARS-CoV-2 infection leads to robust humoral response and antibodies that effectively neutralize variants
por: Bates, Timothy A., et al.
Publicado: (2022)

Rapid generation of drug-resistance alleles at endogenous loci using CRISPR-Cas9 indel mutagenesis
por: Ipsaro, Jonathan J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_g3f1021obbln3q5eikhrjt9585